Israeli researchers on Monday said preliminary data show a second booster shot of the Pfizer and Moderna COVID-19 vaccines will “probably” not create enough antibodies to prevent infection from the omicron variant.
Gili Regev-Yochay, an infectious disease expert at Sheba Medical Center, said the fourth jab increases antibodies “even a little bit higher than what we had after the third dose,” but the increase is likely not enough to prevent omicron, which is considered more transmissible than earlier variants, Reuters reported.
